ALYSSA LAING: Open Payments
NPI 1558874347 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,743 in 44 payments from 11 companies in 2025. Trend: 2023 $1,368 · 2024 $2,489 · 2025 $1,743
Food & beverage: $1,743
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $632 |
| PFIZER INC. | 16 | $230 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $150 |
| Novo Nordisk Inc | 3 | $147 |
| Medtronic, Inc. | 1 | $146 |
| Actelion Pharmaceuticals US, Inc. | 2 | $143 |
| BridgeBio Pharma, Inc. | 2 | $139 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Philips North America LLC | 2 | $30 |
| Boston Scientific Corporation | 1 | $28 |
Products named: CAMZYOS, ELIQUIS, JARDIANCE, SIMULUS, UPTRAVI, Attruby, Wegovy, VYNDAQEL.
Industry payments across KY — which companies pay providers there.
